Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer
Open Access
- 1 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (41), 66880-66891
- https://doi.org/10.18632/oncotarget.11801
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Victoria Villaflor1, Brian Won2, Rebecca Nagy3, Kimberly Banks3, Richard B. Lanman3, AmirAli Talasaz3, Ravi Salgia4 1Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA 2University of Chicago School of Medicine, MC 2115, Chicago, IL 60637, USA 3Guardant Health, Redwood City, CA 94063, USA 4City of Hope, Duarte, CA 91010, USA Correspondence to: Victoria Villaflor, email: victoria.villaflor@nm.org Ravi Salgia, email: rsalgia@coh.org Keywords: circulating tumor DNA, cell-free DNA, non-small cell lung cancer, next-generation sequencing Received: April 17, 2016 Accepted: August 13, 2016 Published: September 01, 2016Keywords
This publication has 52 references indexed in Scilit:
- Plasma T790M Result Alters Treatment Options in a Previously T790 Wild-Type EGFR -Mutant Lung CancerJournal of Thoracic Oncology, 2016
- Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomesAnnals of Oncology, 2015
- Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patientsBreast Cancer Research and Treatment, 2015
- EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291Lung Cancer, 2015
- Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung CancerCancers, 2015
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesScience Translational Medicine, 2014
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancerNature Medicine, 2013
- Minimally Invasive Adenocarcinomas of the LungAdvances in Anatomic Pathology, 2009
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin.2003